- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Physician Opinions on Benefits of Open Visit Notes Vary
Annals of Internal Medicine
Primary care physicians (PCPs) have varied opinions about open access to doctors' notes; and most users of a personal health record (PHR) system are interested in sharing access to their information, according to 2 studies published in the December 20 issue of the .
Jan Walker, R.N., M.B.A., from Harvard Medical School in Boston, and colleagues explored doctors' and patients' attitudes toward access to doctors' notes. Open visit notes were regarded as a good idea by 69 to 81% of the participating PCPs (who shared their notes), 92 to 97% of patients, and 16 to 33% of non-participating PCPs.
Compared to non-participating PCPs, participating PCPs and patients were more likely to agree on the potential benefits of open visit notes, including improved communication and patient education.
Read more at: http://www.physiciansbriefing.com/Article.asp?AID=659893
Source: Health Day
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade
April 18th 2025Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives and itching remain uncontrolled by antihistamines.
Read More
